Jill E Gorze, MD in Bellflower, CA - Medicare Interventional Pain Management

Jill E Gorze, MD is a medicare enrolled "Pain Medicine - Pain Medicine" physician in Bellflower, California. She went to New York Medical College and graduated in 2001 and has 23 years of diverse experience with area of expertise as Interventional Pain Management. She is a member of the group practice Southern California Permanente Medical Group and her current practice location is 9400 Rosecrans Ave, Bellflower, California. You can reach out to her office (for appointments etc.) via phone at (562) 461-3000.

Jill E Gorze is licensed to practice in California (license number A89982) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1356418180.

Contact Information

	Jill E Gorze, MD
	9400 Rosecrans Ave, Bellflower, CA 90706-2246
	(562) 461-3000
	Not Available

Physician's Profile

Full Name	Jill E Gorze
Gender	Female
Speciality	Interventional Pain Management
Experience	23 Years
Location	9400 Rosecrans Ave, Bellflower, California
Accepts Medicare Assignments	Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Jill E Gorze attended and graduated from New York Medical College in 2001

NPI Data:

NPI Number: 1356418180
Provider Enumeration Date: 11/29/2006
Last Update Date: 12/02/2021

Medicare PECOS Information:

PECOS PAC ID: 3072613900
Enrollment ID: I20070706000610

Medical Identifiers

Medical identifiers for Jill E Gorze such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1356418180	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208VP0000X	Pain Medicine - Pain Medicine	A89982 (California)	Primary

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Southern California Permanente Medical Group	6002729175	7951

News Archive

FDA approves Somatuline Depot to treat acromegaly

The U.S. Food and Drug Administration has approved Somatuline Depot (lanreotide acetate injection) for the treatment of acromegaly, a rare and potentially life threatening disease in adults caused by abnormal secretion of growth hormone (GH), commonly from a benign tumor located in the pituitary gland located in the brain.

CDRD, NGDI-UBC collaborate to combine existing approved drugs to better treat TB

One year after The Centre for Drug Research and Development (CDRD) and the Neglected Global Diseases Initiative at the University of British Columbia (NGDI-UBC) came together to develop interventions for neglected global diseases, a project to combine existing approved drugs to better treat Tuberculosis (TB) has emerged as the collaboration's leading prospect.

Study finds moderate or severe signs of depression and anxiety among hospice caregivers

Currently, more than 34 million people in the U.S. care for terminally ill love ones, but few resources are available to help them navigate the challenges they encounter.

Study finds rhinovirus reduces SARS-CoV-2 replication in airway epithelial cells

A recent study has demonstrated that SARS-CoV-2 infection induces a significantly lower interferon response than rhinovirus infection.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Jill E Gorze allows following entities to bill medicare on her behalf.

Entity Name	Southern California Permanente Medical Group
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1770515280 PECOS PAC ID: 6002729175 Enrollment ID: O20031110000678

News Archive

FDA approves Somatuline Depot to treat acromegaly

CDRD, NGDI-UBC collaborate to combine existing approved drugs to better treat TB

Study finds moderate or severe signs of depression and anxiety among hospice caregivers

Currently, more than 34 million people in the U.S. care for terminally ill love ones, but few resources are available to help them navigate the challenges they encounter.

Study finds rhinovirus reduces SARS-CoV-2 replication in airway epithelial cells

A recent study has demonstrated that SARS-CoV-2 infection induces a significantly lower interferon response than rhinovirus infection.

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Jill E Gorze is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Jill E Gorze, MD 9400 Rosecrans Ave, Bellflower, CA 90706-2246 Ph: (562) 461-3000	Jill E Gorze, MD 9400 Rosecrans Ave, Bellflower, CA 90706-2246 Ph: (562) 461-3000

News Archive

FDA approves Somatuline Depot to treat acromegaly

CDRD, NGDI-UBC collaborate to combine existing approved drugs to better treat TB

Study finds moderate or severe signs of depression and anxiety among hospice caregivers

Currently, more than 34 million people in the U.S. care for terminally ill love ones, but few resources are available to help them navigate the challenges they encounter.

Study finds rhinovirus reduces SARS-CoV-2 replication in airway epithelial cells

A recent study has demonstrated that SARS-CoV-2 infection induces a significantly lower interferon response than rhinovirus infection.

Jill E Gorze, MD - Medicare Interventional Pain Management in Bellflower, CA

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Group Practice Association

FDA approves Somatuline Depot to treat acromegaly

CDRD, NGDI-UBC collaborate to combine existing approved drugs to better treat TB

Study finds moderate or severe signs of depression and anxiety among hospice caregivers

Study finds rhinovirus reduces SARS-CoV-2 replication in airway epithelial cells

Medicare Reassignments

FDA approves Somatuline Depot to treat acromegaly

CDRD, NGDI-UBC collaborate to combine existing approved drugs to better treat TB

Study finds moderate or severe signs of depression and anxiety among hospice caregivers

Study finds rhinovirus reduces SARS-CoV-2 replication in airway epithelial cells

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

FDA approves Somatuline Depot to treat acromegaly

CDRD, NGDI-UBC collaborate to combine existing approved drugs to better treat TB

Study finds moderate or severe signs of depression and anxiety among hospice caregivers

Study finds rhinovirus reduces SARS-CoV-2 replication in airway epithelial cells

Pain Medicine Doctors in Bellflower, CA